Novartis AG (NOVN:Virt-x)

When drug maker Novartis chose Holly Springs as the site for a new vaccine plant three and a half years ago, it instantly put the southern Wake County town at the epicenter of the country's efforts to combat the flu. The recipient of more than $700 million in government contracts to make flu vaccine, the plant is the largest of its kind under construction in the country.

From Barcelona to Seoul, urban science parks are being built to lure the best minds and the industries of tomorrow

From Barcelona to Seoul, urban science parks are being built to lure the best minds and the industries of tomorrow

AMMAN -- The Ministry of Health on Tuesday launched a nationwide H1N1 vaccination campaign involving patients and workers most at risk of contracting the disease. At the launch of the campaign at Prince Hamzah Hospital in Amman, ministry officials were the first to receive the shots to preempt any fears or rumours that might ensue.

Corporate news announcement processed and transmitted by Hugin AS.

NVS: Initiated - Deutsche Securities initiated coverage of the shares with a Buy rating.

AMMAN -- The Ministry of Health will start vaccinating today Jordanians classified as high-risk patients against H1N1 flu, a ministry source said Saturday. The ministry last week prepared a plan detailing categories given priority for immunisation.

Of the companies that make the vaccine for the swine flu, only one has avoided the production problems caused by a slow-growing virus strain. AstraZeneca P.L.C.'s MedImmune Inc. is churning out nearly three million doses of its vaccine a week at its facility on Red Lion Road near the Northeast Philadelphia Airport.

11/13/09 -- AspenBio Pharma, Inc., an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, has been invited to present at the Lazard Capital Market 6th Annual Healthcare Conference to be held November 17-18, 2009 at The St. Regis Hotel New York, NY. Company management is scheduled to present on Tuesday, November 17, 2009 at 9:25 a.m. E...

Serbia's health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million. Health officials said Friday the first shipment of some 500,000 doses is to arrive next month, while the rest are due early next year.